In the quarter ended March 31, the cancer institute recorded an operating loss of $16.1 million. Last year, the cancer institute posted a $14.3 million operating loss.
In the second quarter of fiscal 2021, Dana-Farber saw its revenue year over year grow 4.6 percent to $507.8 million. The cancer institute also saw its patient revenue grow 6.7 percent year over year in the second quarter to $362 million.
The health system’s expenses also rose in the second quarter of fiscal 2021 to $523.8 million, up from $500 million recorded in the same quarter last year.
After factoring investment gains, Dana-Farber recorded a net income of $67.3 million in the second quarter of fiscal 2021. In the same period last year, Dana Farber saw a net loss of $118.1 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
